Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

1. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   MaqolaTuberculosis Research and EpidemiologyERJ Open Research20201 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.360284

2. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Jay Achar, Nell Gray +4

   MaqolaTuberculosis Research and EpidemiologyPLoS ONE20201 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.360285